Rapid antigen tests for SARS-CoV-2 : a synopsis of the medical evidence / Christoph Wertenauer, Caroline Pfeifer, Martin Roskos, Winfried März
SARS-CoV-2, the causative agent of the COVID-19 pandemic, continues to influence health, economy, and stability worldwide. Diagnostic testing for SARS-CoV-2 is important to contain the COVID-19 pandemic. With the commercial availability of certified antigen (Ag) rapid diagnostic tests (RDTs), which can be used to identify an infection with SARS-CoV-2 an easy-to-use tool was introduced. Self-tests can offer advantages to complement professionally administered rapid antigen detection or nucleic acid amplification testing (NAAT). Compared to real-time polymerase chain reaction (RT-PCR), Ag-RDTs are cost inexpensive, do not need specialized laboratory equipment, facilitating high-throughput testing. However, Ag-RDT sensitivities are strongly dependent on the viral load within the specimen, which has limited their application in clinical settings so far. The methodical limitations of Ag-RDTs may produce false negative test results, particularly when specimens with low viral loads are examined. This may facilitate viral transmissions if protective measurements are lifted mistakenly..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
October 2023 2023 |
---|---|
Erschienen: |
October 2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:107 |
---|---|
Enthalten in: |
Diagnostic microbiology and infectious disease - 107(2023), 2 vom: Okt., Artikel-ID 116027, Seite 1-6 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wertenauer, Christoph [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antigen test |
---|
Anmerkungen: |
Online veröffentlicht am 14. Juli 2023, Artikelversion vom 27. Juli 2023 Gesehen am 20.12.2023 |
---|
Umfang: |
Illustrationen 6 |
---|
doi: |
10.1016/j.diagmicrobio.2023.116027 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1860127878 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1860127878 | ||
003 | DE-627 | ||
005 | 20240307053559.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230921s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.diagmicrobio.2023.116027 |2 doi | |
035 | |a (DE-627)1860127878 | ||
035 | |a (DE-599)KXP1860127878 | ||
035 | |a (OCoLC)1425212146 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Wertenauer, Christoph |e verfasserin |0 (DE-588)1314144154 |0 (DE-627)1876529253 |4 aut | |
245 | 1 | 0 | |a Rapid antigen tests for SARS-CoV-2 |b a synopsis of the medical evidence |c Christoph Wertenauer, Caroline Pfeifer, Martin Roskos, Winfried März |
264 | 1 | |c October 2023 | |
300 | |b Illustrationen | ||
300 | |a 6 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Online veröffentlicht am 14. Juli 2023, Artikelversion vom 27. Juli 2023 | ||
500 | |a Gesehen am 20.12.2023 | ||
520 | |a SARS-CoV-2, the causative agent of the COVID-19 pandemic, continues to influence health, economy, and stability worldwide. Diagnostic testing for SARS-CoV-2 is important to contain the COVID-19 pandemic. With the commercial availability of certified antigen (Ag) rapid diagnostic tests (RDTs), which can be used to identify an infection with SARS-CoV-2 an easy-to-use tool was introduced. Self-tests can offer advantages to complement professionally administered rapid antigen detection or nucleic acid amplification testing (NAAT). Compared to real-time polymerase chain reaction (RT-PCR), Ag-RDTs are cost inexpensive, do not need specialized laboratory equipment, facilitating high-throughput testing. However, Ag-RDT sensitivities are strongly dependent on the viral load within the specimen, which has limited their application in clinical settings so far. The methodical limitations of Ag-RDTs may produce false negative test results, particularly when specimens with low viral loads are examined. This may facilitate viral transmissions if protective measurements are lifted mistakenly. | ||
650 | 4 | |a Antigen test | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Rapid antigen detection test | |
650 | 4 | |a Rapid diagnostic test | |
650 | 4 | |a RDT | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Pfeifer, Caroline |e verfasserin |4 aut | |
700 | 1 | |a Roskos, Martin |e verfasserin |4 aut | |
700 | 1 | |a März, Winfried |d 1958- |e verfasserin |0 (DE-588)1027603599 |0 (DE-627)729463605 |0 (DE-576)373454635 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnostic microbiology and infectious disease |d Amsterdam [u.a.] : Elsevier Science, 1983 |g 107(2023), 2 vom: Okt., Artikel-ID 116027, Seite 1-6 |h Online-Ressource |w (DE-627)32360479X |w (DE-600)2026024-6 |w (DE-576)264424107 |x 1879-0070 |7 nnns |
773 | 1 | 8 | |g volume:107 |g year:2023 |g number:2 |g month:10 |g elocationid:116027 |g pages:1-6 |g extent:6 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.diagmicrobio.2023.116027 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0732889323001372 |x Verlag |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_252 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4313 | ||
951 | |a AR | ||
952 | |d 107 |j 2023 |e 2 |c 10 |i 116027 |h 1-6 |g 6 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 437863614X |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 21-09-23 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2023 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_4 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_6 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1876530588 |a Wertenauer, Christoph | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416467254 |a Medizinische Fakultät Mannheim | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_1 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1443455210 |a März, Winfried | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416467254 |a Medizinische Fakultät Mannheim | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_4 |